Elevated PAI-1 expression in many cancers, such as glioma, ovarian cancer, and pancreatic cancer, was associated with unfavorable patient outcomes 42, 43, suggesting its potential role in tumor promotion. The gene discussed is SERPINE1; the disease is central nervous system cancer.